Pee Cee Cosma Sope Limited (BOM:524136)
India · Delayed Price · Currency is INR 331.60
+8.70 (2.69%)
At close: May 29, 2026
Pee Cee Cosma Sope Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,580 | 1,406 | 1,336 | 1,245 | 926.93 |
Other Revenue | 2.72 | - | - | - | - |
| 1,582 | 1,406 | 1,336 | 1,245 | 926.93 | |
Revenue Growth (YoY) | 12.55% | 5.20% | 7.33% | 34.33% | 12.69% |
Cost of Revenue | 1,148 | 1,000 | 909.18 | 947.09 | 701.34 |
Gross Profit | 434.53 | 405.5 | 427.25 | 298.07 | 225.58 |
Selling, General & Admin | 142.15 | 164.89 | 170.43 | 144.76 | 117.34 |
Other Operating Expenses | 163.06 | 110.43 | 101.74 | 100.73 | 80.24 |
Operating Expenses | 321.65 | 291.65 | 288.2 | 260.59 | 204.16 |
Operating Income | 112.88 | 113.85 | 139.05 | 37.48 | 21.42 |
Interest Expense | -0.91 | -2.04 | -2.84 | -8.58 | -3.95 |
Interest & Investment Income | - | 4.15 | 5.1 | 5.16 | 6.04 |
Other Non Operating Income (Expenses) | - | 0.19 | 0.1 | -0.03 | -0.68 |
EBT Excluding Unusual Items | 111.96 | 116.16 | 141.4 | 34.04 | 22.83 |
Gain (Loss) on Sale of Investments | - | 5.62 | 0.64 | - | - |
Gain (Loss) on Sale of Assets | - | 7.27 | 0.01 | -0.03 | - |
Asset Writedown | - | - | -1.54 | -0.7 | - |
Other Unusual Items | - | 0.01 | 0.03 | 0.03 | 0.04 |
Pretax Income | 111.96 | 129.06 | 140.55 | 33.33 | 22.87 |
Income Tax Expense | 28.69 | 32.97 | 36.11 | 8.47 | 6.01 |
Net Income | 83.27 | 96.09 | 104.44 | 24.86 | 16.85 |
Net Income to Common | 83.27 | 96.09 | 104.44 | 24.86 | 16.85 |
Net Income Growth | -13.35% | -7.99% | 320.07% | 47.52% | -64.64% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | -0.11% | - | - | - | - |
EPS (Basic) | 31.50 | 36.31 | 39.47 | 9.40 | 6.37 |
EPS (Diluted) | 31.50 | 36.30 | 39.47 | 9.40 | 6.37 |
EPS Growth | -13.22% | -8.02% | 320.07% | 47.52% | -64.64% |
Free Cash Flow | 139.8 | 53.32 | 92.93 | 24.49 | -13.5 |
Free Cash Flow Per Share | 52.88 | 20.15 | 35.12 | 9.25 | -5.10 |
Dividend Per Share | - | 3.000 | 3.000 | 2.000 | 1.000 |
Dividend Growth | - | - | 50.00% | 100.00% | -66.67% |
Gross Margin | 27.46% | 28.84% | 31.97% | 23.94% | 24.34% |
Operating Margin | 7.13% | 8.10% | 10.40% | 3.01% | 2.31% |
Profit Margin | 5.26% | 6.83% | 7.81% | 2.00% | 1.82% |
Free Cash Flow Margin | 8.83% | 3.79% | 6.95% | 1.97% | -1.46% |
EBITDA | 129.31 | 129.45 | 154.34 | 51.83 | 27.54 |
EBITDA Margin | 8.17% | 9.21% | 11.55% | 4.16% | 2.97% |
D&A For EBITDA | 16.44 | 15.6 | 15.29 | 14.35 | 6.12 |
EBIT | 112.88 | 113.85 | 139.05 | 37.48 | 21.42 |
EBIT Margin | 7.13% | 8.10% | 10.40% | 3.01% | 2.31% |
Effective Tax Rate | 25.63% | 25.54% | 25.69% | 25.40% | 26.30% |
Revenue as Reported | 1,582 | 1,423 | 1,342 | 1,251 | 933.04 |
Advertising Expenses | - | 42.59 | 62.39 | 44.58 | 26.56 |